Abstract
Paraoxonase 1 (PON1: EC 3.1.8.1) is a calcium-dependent enzyme associated with high-density lipoproteins (HDLs) and has a protective effect against oxidation of low-density lipoproteins (LDLs) in mammals. PON1 is the best-studied member of a family of enzymes called serum paraoxonases, or PONs, identified in mammals and other vertebrates as well as in invertebrates. PONs exhibit a range of important activities, including drug metabolism and detoxification of organophosphates such as nerve agents. This study reports, for the first time, purification and biochemical characterization of serum PON1 from different bovine breeds namely Swiss Black, Holstein, and Montofon. Bovine serum PON1s were purified using ammonium sulfate precipitation followed by Sepharose-4B-l-tyrosine-1-naphthylamine hydrophobic interaction chromatography. SDS–polyacrylamide gel electrophoresis of the purified enzymes indicates a single band with an apparent MW of 43 kDa. The purified enzymes had a specific activity of 10.78, 27.00, and 22.38 U/mg for Swiss Black, Holstein, and Montofon bovines, respectively. The overall purification rates of our method were 262.47-, 2,476.90-, and 538.06-fold for Swiss Black, Holstein, and Montofon bovines, respectively. Furthermore, using phenyl acetate as a substrate, we determined the K M and V max values of the purified enzymes, as 0.80 mM, 1428.5 U/ml for Swiss Black; 0.40 mM, 714.3 U/ml for Holstein; and 0.50 mM, 1,111.1 U/ml for Montofon bovine. The present study has revealed that there is no substantial difference in PON1 activities among the studied bovine breeds.
Similar content being viewed by others
References
Draganov, D. I., & La Du, B. N. (2004). Archives of Pharmacology, 369, 78–88.
La Du, B. N., Aviram, M., Billecke, S., et al. (1999). Chemico-Biological Interactions, 119–120, 379–388.
Getz, G. S., & Reardon, C. A. (2004). Paraoxonase, a cardioprotective enzyme: continuing issues. Current Opinion in Lipidology, 15, 261–267.
Aldridge, W. N. (1953). Biochemical Journal, 53, 110.
Biggadike, K., Angell, R. M., Burgess, C. M., et al. (2000). Journal of Medicinal Chemistry, 43, 19–21.
Lusis, A. J. (2000). Nature, 407, 233–241.
Aviram, M., Billecke, S., Sorenson, R., et al. (1998). Arteriosclerosis, Thrombosis, and Vascular Biology, 18, 1617–1624.
Arslan, M., Erzengin, M., & Demir, D. (2011). Journal of Animal and Veterinary Advances, 10(4), 489–494.
Kuo, C. L., & La Du, B. N. (1998). Drug Metabolism and Disposition, 26, 653–660.
Gil, F., Pla, A., Gonzalvo, M. C., et al. (1993). Chemico-Biological Interactions, 87, 69–75.
Erzengin, M., Başaran, I., Çakir, U., Aybey, A., & Sinan, S. (2012). Applied Biochemistry and Biotechnology, 168, 1540–1548.
Brealey, C. J., Walker, C. H., & Baldwin, B. C. (1980). Pesticide Science, 11, 546–554.
Furlong, C. E., Li, W. F., Shih, D. M., et al. (2002). Human and Ecological Risk Assessment, 8(1), 31–43.
Turk, R., Juretic, D., Geres, D., et al. (2004). Research in Veterinary Science, 76, 57–61.
Turk, R., Juretic, D., Geres, D., et al. (2005). Research in Veterinary Science, 79, 15–18.
Eckerson, H. W., Wyte, C. M., & La Du, B. N. (1983). American Journal of Human Genetics, 35, 1126.
La Du, B. N. (1992). In Pharmacogenetics of drug metabolism (pp. 51–91). New York: Pergamon Press.
Nogueira, C. P., Evans, D. A., & La Du, B. N. (1993). Pharmacogenetics, 3, 144–149.
Yamasaki, Y., Sakamoto, K., Watada, H., et al. (1997). Human Genetics, 101, 67–68.
Mackness, B., Mackness, M. I., Durrington, P. N., et al. (2000). European Journal of Clinical, 30, 4–10.
Mounter, L. A., Floyd, C. S., & Chanutin, A. (1953). The Journal of Biological Chemistry, 204, 221–232.
Gan, K. N., Smolen, A., Eckerson, H. W., & La Du, B. N. (1991). Drug Metabolism and Disposition, 19, 100–106.
Mazur, A. (1946). The Journal of Biological Chemistry, 164, 271–289.
Main, A. R. (1956). Canadian Journal of Biochemistry and Physiology, 34, 197.
Rodrigo, L., Gil, F., Hernandez, A. F., et al. (1997). Biochemical Journal, 321, 595–601.
Rodrigo, L., Gil, F., Hernandez, A. F., et al. (2003). Biochemical Journal, 15, 261–268.
Mackness, B., Durrington, P. N., & Mackness, M. I. (1998). General Pharmacology, 31, 329–336.
Costa, L. G., Richter, R. J., Li, W. F., et al. (2003). Biomarkers, 8, 1–12.
Ferre, N., Camps, J., Prats, E., et al. (2002). Clinical Chemistry, 48, 261–268.
Ahmed, M. M., Elserougy, E. M., Al-Gazzar, I. I., et al. (2013). EXCLI Journal, 12, 719–732.
Aviram, M., & Rosenblat, M. (2004). Free Radical Biology and Medicine, 9, 1304–1316.
Sinan, S., Koçkar, F., & Arslan, O. (2006). Biochimie, 88, 565–574.
Bradford, M. M. (1976). Analytical Biochemistry, 72, 248–251.
Laemmli, U. K. (1970). Nature, 227, 680–685.
Furlong, C. E., Richter, R. J., Chapline, C., & Crabb, J. W. (1991). Biochemistry, 30, 10133–10140.
Miyamoto, T., Takahashi, Y., Oohashi, T., et al. (2005). Journal of Veterinary Medicine, 67(3), 243–248.
Mackness, M. I., Halam, S. D., Peard, T., et al. (1985). Comparative Biochemistry and Physiology, 82, 675.
Zimmerman, J. K., Grothusen, J. R., Bryson, P. K., & Brown, T. M. (1989). In enzymes hydrolyzing organophosphorus compounds (pp. 128–142). Chichester: Ellis Horwood Ltd.
Hassett, C., Richter, R. J., Humbert, R., et al. (1991). Biochemistry, 30, 10141.
Samra, Z. Q., Shabir, S., Rehmat, Z., et al. (2010). Applied Biotechnology and Biochemistry, 162, 671–686.
Acknowledgments
This work was carried out in the Balikesir University Research Center of Applied Sciences (BURCAS).
Declaration of Interest
The authors declare that there are no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Erzengin, M., Demir, D., Arslan, M. et al. Purification and Characterization of Paraoxonase 1 (PON1) from Swiss Black, Holstein, and Montofon Bovines. Appl Biochem Biotechnol 173, 1597–1606 (2014). https://doi.org/10.1007/s12010-014-0931-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-014-0931-1